Saturday, July 29th, 2023

Special Edition: Ozempic - Beyond the Hype

Listen below:

Tune in weekdays for 10-min daily news roundups:

Ozempic is approved to treat Type 2 diabetes. But because the drug can also lead to weight loss, its popularity has surged. Dr. Omer Awan explains how the drug works and his biggest concerns about it. Then, celebrity dietician Kim Shapira shares why she thinks Ozempic can be a “lifeline” for many people and why it’s been compared to Botox. 

This episode was sponsored by:

BetterHelp: https://www.BetterHelp.com/newsworthy 

AG1: https://www.drinkAG1.com/newsworthy

Get ad-free episodes by becoming an insider: www.theNewsWorthy.com/insider 

Guest: Kim Shapira, MS, RD

Kim Shapira is a celebrity dietitian, nutritional therapist, and author of “This Is What You’re Really Hungry For.” She has spent 25+ years helping people lose weight and keep it off, seeing patients in her private Los Angeles practice, in hospitals, sports clinics, addiction centers, and universities.

Kim has a Bachelor of Science in Kinesiology from Tulane University and a Master’s degree in Human Metabolism and Clinical Nutrition from Boston University.








.



Guest: Omer Awan, MD, MPH

Dr. Omer Awan is a practicing physician, a professor at the University of Maryland School of Medicine, and a public health contributor for Forbes.

He seeks to educate the public on important healthcare and public health topics, attempting to make complex topics easy for the general population to understand. He has a YouTube channel entitled "MedEdPage" that does just that.









 




.


 
 
 

Be sure to tune-in again each weekday (M-F) for our regular episodes to get quick, unbiased news roundups in ~10 minutes! 

LISTEN TO THE LATEST EPISODE OF

THE NEWSWORTHY: